神経刺激デバイスの市場規模、シェア、成長分析：タイプ別、用途別、地域別 - 産業予測、2024-2031年

神経刺激デバイスの世界市場規模は、2022年に53億米ドルと評価され、2023年の59億8,000万米ドルから2031年には156億7,000万米ドルに達し、予測期間（2024-2031年）のCAGRで12.80%の成長が予測されています。

神経刺激は、埋込型医療機器を利用して神経活動を調整・変化させる治療技術です。このプロセスで使用される機器は神経刺激デバイスと呼ばれ、治療には脳、末梢神経系、脊髄の標的部位に電気インパルスを送ることが含まれます。神経刺激は、パーキンソン病、てんかん、慢性疼痛、うつ病などの神経疾患の管理に特に有効です。パーキンソン病やジストニアなど、慢性的なストレスや社会的制限によって症状が悪化する可能性のある患者に対して、電気刺激を与えることで症状を緩和し、生活の質を高めることができます。神経刺激デバイスの市場は、高齢化、先端技術の市場開拓、補助療法としての使用の増加、片頭痛やてんかんのような慢性疾患の有病率の上昇など、いくつかの要因によって拡大しています。さらに、アンメットメディカルニーズの高さ、神経疾患の負担増、外部研究資金の獲得、低侵襲手技への嗜好などが市場成長の原動力となっています。例えば、脳卒中とアルツハイマー病は米国における主な死因であり、パーキンソン病は100万人近い米国人が罹患し、毎年6万人以上が新たに発症しています。これらの疾患の発症率が上昇するにつれて、神経刺激デバイスの需要は伸びると予測されます。メーカー各社は、これらの技術を進歩させるための研究に投資しており、侵襲性の低い製品を提供することで、入院期間の短縮や回復時間の短縮につなげることを目指しています。

目次

イントロダクション

• 調査の目的
• 定義
• 市場範囲

調査手法

• 情報調達
• 二次データソースと一次データソース
• 市場規模予測
• 市場の想定と制限

エグゼクティブサマリー

• 市場概要見通し
• 供給需要動向分析
• セグメント別機会分析

市場力学と見通し

• 市場力学
  • 促進要因
  • 機会
  • 抑制要因
  • 課題
• ポーターの分析

主な市場の考察

• 市場の成功要因
• 競合の程度
• 主な投資機会
• 市場魅力度指数
• エコシステムマッピング
• 技術分析
• コスト分析
• 市場動向分析
• 競合分析
• サプライチェーン分析
• 投資分析
• アプリケーション固有の分析
• 特許分析
• 貿易分析
• ケーススタディ分析
• ポーターのファイブフォース分析

神経刺激デバイス市場：タイプ別

• 市場概要
• 内部神経調節
  • 脊髄刺激
  • 脳深部刺激
  • 迷走神経刺激
  • 仙骨神経刺激
  • 胃電気刺激
• 外部神経調節
  • 経皮的電気神経刺激（TENS）
  • 経頭蓋磁気刺激（TMS）
  • 呼吸電気刺激（RES）

神経刺激デバイス市場：用途別

• 市場概要
• 脊髄刺激
  • フェイルバック症候群
  • 慢性疼痛
  • 虚血
• 脳深部刺激
  • パーキンソン病
  • 振戦
  • うつ病
  • その他
• 仙骨神経刺激
  • 尿失禁
  • 便失禁
• 迷走神経刺激
  • てんかん
  • その他
• 胃電気刺激
  • 胃不全麻痺
  • 肥満
• 経皮的電気神経刺激
  • 治療抵抗性うつ病
  • その他
• 経頭蓋磁気刺激
  • うつ病
  • 片頭痛
• 呼吸電気刺激
  • 脊髄損傷

神経刺激デバイス市場規模：地域別

• 市場概要
• 北米
  • 米国
  • カナダ
• 欧州
  • ドイツ
  • 英国
  • フランス
  • イタリア
  • スペイン
  • その他欧州地域
• アジア太平洋地域
  • 中国
  • インド
  • 日本
  • 韓国
  • その他アジア太平洋地域
• ラテンアメリカ
  • ブラジル
  • その他ラテンアメリカ地域
• 中東・アフリカ（MEA）
  • GCC諸国
  • 南アフリカ
  • その他中東・アフリカ地域

競合情勢

• 上位5社の比較
• 主要企業の市場ポジショニング（2023年）
• 主な市場企業が採用した戦略
• 市場における最近の活動
• 主要企業の市場シェア（2023年）

主要企業プロファイル

• Medtronic（Ireland）
• Abbott Laboratories（US）
• Boston Scientific Corporation（US）
• LivaNova PLC（U.K.）
• Nevro Corp.（US）
• NeuroPace, Inc.（US）
• Synapse Biomedical Inc.（US）
• Neuronetics, Inc.（US）
• NDI Medical LLC（US）
• Stimwave Technologies（US）
• BioControl Medical（Israel）
• EndoStim（US）
• Aleva Neurotherapeutics（Switzerland）
• SPR Therapeutics（US）
• electroCore, Inc.（US）
• Soterix Medical Inc.（US）
• Cala Health（US）
• Inspire Medical Systems, Inc.（US）
• NeuroSigma, Inc.（US）
• Autonomic Technologies Inc.（US）
• Axonics Modulation Technologies, Inc.（US）
• Nexstim Plc（Finland）

Global Neurostimulation Devices Market size was valued at USD 5.3 Billion in 2022 and is poised to grow from USD 5.98 Billion in 2023 to USD 15.67 Billion by 2031, at a CAGR of 12.80% during the forecast period (2024-2031).

Neurostimulation is a therapeutic technique that utilizes implantable medical devices to regulate and alter neural activity. The devices employed in this process are known as neurostimulators, and the therapy involves delivering electrical impulses to targeted regions of the brain, peripheral nervous system, or spinal cord. Neurostimulation is particularly effective in managing neurological disorders like Parkinson's disease, epilepsy, chronic pain, and depression. It works by providing electrical stimulation that can help alleviate symptoms and enhance the quality of life for patients with conditions such as Parkinson's disease or dystonia, who may experience worsened symptoms due to chronic stress and social restrictions. The market for neurostimulation devices is expanding due to several factors, including an aging population, the development of advanced technologies, increasing use as adjunctive therapy, and the rising prevalence of chronic conditions like migraines and epilepsy. Additionally, high unmet medical needs, the growing burden of neurological disorders, external research funding, and a preference for minimally invasive procedures are driving market growth. For instance, stroke and Alzheimer's disease are major causes of death in the U.S., with Parkinson's disease affecting nearly one million Americans and over 60,000 new cases annually. As the incidence of these diseases rises, the demand for neurostimulation devices is projected to grow. Manufacturers are investing in research to advance these technologies, aiming to offer products that are less invasive, leading to shorter hospital stays and quicker recovery times, which will further propel market growth.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Neurostimulation Devices market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Neurostimulation Devices Market Segmental Analysis

The Global Neurostimulation Devices market is segmented by type, Application, and region. Based on type, the market can be segmented into Internal Neuromosulation (Spinal Cord Stimulator, Deep Brain Stimulator, Sacral Nerve Stimulator, Vagus Nerve Stimulator, Gastric Electric Stimulator) External neuromodulation (Transcutaneous Electrical Nerve Stimulation (TENS), Transcranial Magnetic Stimulation (TMS), Respiratory Electrical Stimulation (RES)). Based on Application, the market is segmented into Spinal Cord Stimulation (Failed Back Syndrome, Chronic Pain, Ischemia), Deep Brain Stimulation (Parkinson's Disease, Tremor, Depression, Others), Sacral Nerve Stimulation (Urine Incontinence, Fecal Incontinence), Vagus Nerve Stimulation (VNS) (Epilepsy, Others), Gastric Electrical Stimulation (Gastroparesis, Obesity), Transcutaneous Electrical Nerve Stimulation (Treatment-resistant Depression, Others), Transcranial Magnetic Stimulation (Depression, Migraine Headache), Respiratory Electrical Stimulation (Spinal Cord Injury). Based on region, the market is segmented into North America, Europe, Asia Pacific, Middle East and Africa, and Latin America.

Drivers of the Global Neurostimulation Devices Market

A major driver of the neurostimulation devices market is the escalating prevalence of neurological disorders globally. According to the World Health Organization, neurological conditions contribute significantly to the global disease burden, impacting millions of individuals. The rising incidence of disorders such as Parkinson's disease, epilepsy, and chronic pain is increasing the demand for neurostimulation devices, which offer effective treatment solutions. This growing need for advanced therapies is prompting manufacturers to invest heavily in research and development to create innovative neurostimulation devices. Such advancements are anticipated to further drive market expansion.

Restraints in the Global Neurostimulation Devices Market

Despite the increasing demand for neurostimulation devices, several factors are hindering market growth. One major restraint is the high cost of these devices, which poses a significant financial burden on patients, particularly in low- and middle-income countries. Additionally, the shortage of skilled healthcare professionals and the limited availability of neurostimulation devices in certain regions further restrict market expansion. Moreover, potential risks related to device implantation, such as infections and device malfunctions, also contribute to market challenges.

Market Trends of the Global Neurostimulation Devices Market

A prominent trend in the neurostimulation devices market is the advancement of minimally invasive and non-invasive technologies. These innovations are increasingly favored due to their benefits over traditional surgical methods, such as reduced pain, shorter hospital stays, and quicker recovery periods. Additionally, the emergence of wireless and implantable devices is contributing to market growth, as they enhance patient comfort by eliminating the need for external wires and bulky equipment. This shift towards less invasive neurostimulation solutions is anticipated to drive continued market expansion in the coming years.

Table of Contents

Introduction

• Objectives of the Study
• Definitions
• Market Scope

Research Methodology

• Information Procurement
• Secondary & Primary Data Sources
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Market Overview Outlook
• Supply Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Dynamics
  • Drivers
  • Opportunities
  • Restraints
  • Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of Substitute Products
  • Bargaining Power of Buyers
  • Threat of New Entrants
  • Bargaining Power of Suppliers

Key Market Insights

• Key Success Factors of The Market
• Degree Of Competition
• Top Investment Pockets
• Market Attractive Index
• Ecosystem Mapping
• Technology Analysis
• Cost Analysis
• Market Trend Analysis
• Competition Analysis
• Supply chain analysis
• Investment Analysis
• Application-Specific Analysis
• Patent analysis
• Trade analysis
• Case study analysis
• Porter's five forces analysis

Global Neurostimulation Devices Market by Type

• Market overview
• Internal Neuromodulation
  • Spinal Cord Stimulation
  • Deep Brain Stimulation
  • Vagus Nerve Stimulation
  • Sacral Nerve Stimulation
  • Gastric Electrical Stimulation
• External Neuromodulation
  • Transcutaneous Electrical Nerve Stimulation (TENS)
  • Transcranial Magnetic Stimulation (TMS)
  • Respiratory Electrical Stimulation (RES)

Global Neurostimulation Devices Market by Application

• Market Overview
• Spinal Cord Stimulation Market
  • Failed Back Syndrome
  • Chronic Pain
  • Ischemia
• Deep Brain Stimulation Market
  • Parkinson's Disease
  • Tremor
  • Depression
  • Other DBS Applications
• Sacral Nerve Stimulation Market
  • Urine Incontinence
  • Fecal Incontinence
• Vagus Nerve Stimulation Market
  • Epilepsy
  • Other VNS Applications
• Gastric Electrical Stimulation Market
  • Gastroparesis
  • Obesity
• Transcutaneous Electrical Nerve Stimulation Market
  • Treatment-resistant Depression
  • Other TENS Applications
• Transcranial Magnetic Stimulation Market
  • Depression
  • Migraine Headache
• Respiratory Electrical Stimulation Market
  • Spinal Cord Injury

Global Neurostimulation Devices Market Size by Region

• Market Overview
• North America
  • USA
  • Canada
• Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Rest of Europe
• Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America
  • Brazil
  • Rest of Latin America
• Middle East & Africa (MEA)
  • GCC Countries
  • South Africa
  • Rest of MEA

Competitive Landscape

• Top 5 Player Comparison
• Market Positioning of Key Players, 2023
• Strategies Adopted by Key Market Players
• Recent Activities in the Market
• Key Companies Market Share (%), 2023

Key Company Profiles

• Medtronic (Ireland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Abbott Laboratories (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Boston Scientific Corporation (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• LivaNova PLC (U.K.)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Nevro Corp. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• NeuroPace, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Synapse Biomedical Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Neuronetics, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• NDI Medical LLC (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Stimwave Technologies (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• BioControl Medical (Israel)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• EndoStim (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Aleva Neurotherapeutics (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• SPR Therapeutics (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• electroCore, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Soterix Medical Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cala Health (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Inspire Medical Systems, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• NeuroSigma, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Autonomic Technologies Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Axonics Modulation Technologies, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Nexstim Plc (Finland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments